Skip to main content

Table 4 Selected parameters (Mean ± SE) before and 6 months after introduction of progesterone (n = 8)

From: A randomized trial of transdermal and oral estrogen therapy in adolescent girls with hypogonadism

 

Before progesterone

On progesterone

Height (cm)

152 ± 2.2

153.3 ± 2.2a

Weight (kg)

50.3 ± 7.7

53.1 ± 7.2a

Estradiol (pg/mL)

26 ± 10.4

11 ± 3.7

Estrone Sulfate (ng/dL)

204 ± 75

217 ± 115

HS-CRP (mg/L)

1.82 ± 1.42

3.83 ± 1.94

Fibrinogen Activity (mg/dL)

267 ± 32.2

310 ± 30.5

Antithrombin Activity (%)

109 ± 3.1

117 ± 7.2

Glucose (mg/dL)

81 ± 2.2

80 ± 1.6

ALT (U/L)

21 ± 5.5

26 ± 7.8

Triglycerides (mg/dL)

122 ± 23.6

111 ± 20

LDL (mg/dL)

84 ± 6.8

84 ± 5.7

IGF-1 (ng/mL)

416 ± 55

314 ± 56

Menses

 

50 %

  1. ap < 0.05, difference in mean values between groups.